Metsera shareholders vote for $10 billion acquisition by Pfizer
13/11/2025 14:13
Nov 13 (Reuters) - Metsera MTSR.O shareholders on Thursday approved Pfizer's PFE.N takeover offer worth up to $10 billion, allowing the U.S. pharmaceutical giant re-entry into the lucrative obesity treatment market after a fierce bidding war with Wegovy-maker Novo Nordisk NOVOb.CO. (Reporting by Kamal Choudhury and Mariam Sunny in Bengaluru; Editing by Maju Samuel) ((Kamal.Choudhury@thomsonreuters.com;))
Recent news on Metsera
See all newsFactbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Factbox: Major deals involving US drugmakers and biotechs over the past decade
Factbox: Major deals involving US drugmakers and biotechs over the past decade
Factbox: Major deals involving US drugmakers and biotechs over the past decade
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up